Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer
Clinical trial NCT06530303 · RECRUITING
Trial details
- NCT number
- NCT06530303
- Sponsor
- Essen Biotech
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-29
- Primary completion
- 2026-09-10
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.